213 related articles for article (PubMed ID: 36702062)
1. Views about neuromodulation interventions for depression by stakeholder group, treatment modality, and depression severity.
Cabrera LY; Achtyes ED; Bluhm R; McCright AM
Compr Psychiatry; 2023 Apr; 122():152365. PubMed ID: 36702062
[TBL] [Abstract][Full Text] [Related]
2. Perceived Barriers to Using Neurostimulation: A National Survey of Psychiatrists, Patients, Caregivers, and the General Public.
Cortright MK; Bluhm R; Achtyes ED; McCright AM; Cabrera LY
J ECT; 2024 Jun; 40(2):111-117. PubMed ID: 38265758
[TBL] [Abstract][Full Text] [Related]
3. Stakeholders' Ethical Concerns Regarding Psychiatric Electroceutical Interventions: Results from a US Nationwide Survey.
Bluhm R; Sipahi ED; Achtyes ED; McCright AM; Cabrera LY
AJOB Empir Bioeth; 2024; 15(1):11-21. PubMed ID: 37343219
[TBL] [Abstract][Full Text] [Related]
4. The differential effects of psychiatrists' and patients' prior experiences on views about psychiatric electroceutical interventions.
Cunningham JE; Bluhm R; Achtyes ED; McCright AM; Cabrera LY
J Psychiatr Res; 2024 Feb; 170():11-18. PubMed ID: 38101204
[TBL] [Abstract][Full Text] [Related]
5. They Affect the Person, but for Better or Worse? Perceptions of Electroceutical Interventions for Depression Among Psychiatrists, Patients, and the Public.
Bluhm R; Castillo E; Achtyes ED; McCright AM; Cabrera LY
Qual Health Res; 2021 Nov; 31(13):2542-2553. PubMed ID: 34672815
[TBL] [Abstract][Full Text] [Related]
6. Looking through the lens of stigma: Understanding and anticipating concerns about the responsible development and use of psychiatric electroceutical interventions (PEIs).
Chen SC; Bluhm R; Achtyes ED; McCright AM; Cabrera LY
SSM Ment Health; 2023 Dec; 4():. PubMed ID: 38188866
[TBL] [Abstract][Full Text] [Related]
7. A qualitative study of key stakeholders' perceived risks and benefits of psychiatric electroceutical interventions.
Cabrera LY; Nowak GR; McCright AM; Achtyes E; Bluhm R
Health Risk Soc; 2021; 23(5-6):217-235. PubMed ID: 35574212
[TBL] [Abstract][Full Text] [Related]
8. Last Resort Interventions?: A Qualitative Study of Psychiatrists' Experience with and Views on Psychiatric Electroceutical Interventions.
Cabrera LY; Nowak GR; McCright AM; Achtyes E; Bluhm R
Psychiatr Q; 2021 Jun; 92(2):419-430. PubMed ID: 32789719
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review.
Moreines JL; McClintock SM; Holtzheimer PE
Brain Stimul; 2011 Jan; 4(1):17-27. PubMed ID: 21255751
[TBL] [Abstract][Full Text] [Related]
10. "They Are Invasive in Different Ways.": Stakeholders' Perceptions of the Invasiveness of Psychiatric Electroceutical Interventions.
Bluhm R; Cortright M; Achtyes ED; Cabrera LY
AJOB Neurosci; 2023; 14(1):1-12. PubMed ID: 34387539
[TBL] [Abstract][Full Text] [Related]
11. Beyond the Cuckoo's Nest: Patient and Public Attitudes about Psychiatric Electroceutical Interventions.
Cabrera LY; Gilbert MMC; McCright AM; Achtyes ED; Bluhm R
Psychiatr Q; 2021 Dec; 92(4):1425-1438. PubMed ID: 33864542
[TBL] [Abstract][Full Text] [Related]
12. Assessing and improving public mental health literacy concerning rTMS.
Morrison AS; Uusberg A; Ryan J; Goldenberg A; Etkin A; Gross JJ
BMC Psychiatry; 2022 Apr; 22(1):249. PubMed ID: 35395758
[TBL] [Abstract][Full Text] [Related]
13. Neuromodulatory treatments for psychiatric disease: A comprehensive survey of the clinical trial landscape.
Elias GJB; Boutet A; Parmar R; Wong EHY; Germann J; Loh A; Paff M; Pancholi A; Gwun D; Chow CT; Gouveia FV; Harmsen IE; Beyn ME; Santarnecchi E; Fasano A; Blumberger DM; Kennedy SH; Lozano AM; Bhat V
Brain Stimul; 2021; 14(5):1393-1403. PubMed ID: 34461326
[TBL] [Abstract][Full Text] [Related]
14. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
McLoughlin DM; Mogg A; Eranti S; Pluck G; Purvis R; Edwards D; Landau S; Brown R; Rabe-Heskith S; Howard R; Philpot M; Rothwell J; Romeo R; Knapp M
Health Technol Assess; 2007 Jul; 11(24):1-54. PubMed ID: 17580003
[TBL] [Abstract][Full Text] [Related]
15. Neuromodulation approaches for the treatment of major depression: challenges and recommendations from a working group meeting.
Brunoni AR; Teng CT; Correa C; Imamura M; Brasil-Neto JP; Boechat R; Rosa M; Caramelli P; Cohen R; Del Porto JA; Boggio PS; Fregni F
Arq Neuropsiquiatr; 2010 Jun; 68(3):433-51. PubMed ID: 20602051
[TBL] [Abstract][Full Text] [Related]
16. Transcranial and deep brain stimulation approaches as treatment for depression.
Rau A; Grossheinrich N; Palm U; Pogarell O; Padberg F
Clin EEG Neurosci; 2007 Apr; 38(2):105-15. PubMed ID: 17515176
[TBL] [Abstract][Full Text] [Related]
17. A clinical repetitive transcranial magnetic stimulation service in Australia: 6 years on.
Galletly CA; Clarke P; Carnell BL; Gill S
Aust N Z J Psychiatry; 2015 Nov; 49(11):1040-7. PubMed ID: 26508800
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression.
Guo B; Zhang M; Hao W; Wang Y; Zhang T; Liu C
Transl Psychiatry; 2023 Jan; 13(1):5. PubMed ID: 36624089
[TBL] [Abstract][Full Text] [Related]
19. Leveraging Neuroplasticity to Enhance Adaptive Learning: The Potential for Synergistic Somatic-Behavioral Treatment Combinations to Improve Clinical Outcomes in Depression.
Wilkinson ST; Holtzheimer PE; Gao S; Kirwin DS; Price RB
Biol Psychiatry; 2019 Mar; 85(6):454-465. PubMed ID: 30528745
[TBL] [Abstract][Full Text] [Related]
20. Are neuromodulation interventions associated with changes in the gut microbiota? A systematic review.
Korenblik V; Brouwer ME; Korosi A; Denys D; Bockting CLH; Brul S; Lok A
Neuropharmacology; 2023 Feb; 223():109318. PubMed ID: 36334762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
